Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;31:232-236

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alonso-Galicia, M.
Right arrow Articles by Roman, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alonso-Galicia, M.
Right arrow Articles by Roman, R. J.

(Hypertension. 1998;31:232.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Induction of P4504A Activity Improves Pressure-Natriuresis in Dahl S Rats

Magdalena Alonso-Galicia; Bruce Frohlich; Richard J. Roman

From the Department of Physiology (M.A.-G., B.F., R.J.R.) Medical College of Wisconsin, Milwaukee, Wisc.

Correspondence to Dr. Richard J. Roman, Department of Physiology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, Wisconsin 53226-0509. E-mail: rroman{at}post.its.mcw.edu

Clofibrate has been reported to prevent the development of hypertension in Dahl S rats, but its mechanism of action remains to be determined. The present study examined the effects of clofibrate on renal P4504A activity and the pressure natriuresis relationship in Dahl S rats. Dahl S and R rats fed a low-salt diet (0.4% NaCl) were given either clofibrate (240 mg/kg/d) or vehicle (20 mmol/L Na2CO3) in their drinking water for 1 week and then switched to a high salt diet (8% NaCl) while continuing drug treatment. After 3 weeks, mean arterial pressure in ketamine-Inactin anesthetized rats averaged 121±2 (n=8) in Dahl R, 173±8 (n=6) in Dahl S, and 139±4 mm Hg (n=7) in clofibrate-treated Dahl S rats. Increasing renal perfusion pressure (RPP) from 100 to 150 mm Hg in Dahl R rats increased sodium excretion (UNaV) from 2.9±0.7 to 9.7±3.2 µmol/min/g kwt. In contrast, the pressure natriuresis relation was blunted in Dahl S rats and UNaV only increased from 2.7±0.9 to 6.1±1.3 µmol/min/g kwt. The pressure natriuresis relation was improved in clofibrate-treated Dahl S rats and UNaV increased from 5.1±1.3 to 16.7±2.6 µmol/min/g kwt. At similar levels of RPP, the fractional excretion of sodium tended to be higher in clofibrate-treated than in vehicle-treated Dahl S rats, but not significantly. Glomerular filtration rate (GFR) was 40% higher in clofibrate-compared to vehicle-treated Dahl S rats (0.9±0.2 versus 0.6±0.2 mL/min/g kwt), and was not significantly different from the values seen in Dahl R rats (0.9±0.1 mL/min/g kwt). Clofibrate induced the expression of P4504A protein in the renal cortex and outer medulla of Dahl S rats. These data suggest that induction of renal P4504A activity with clofibrate improves the pressure natriuresis relation in Dahl S rats by primarily increasing GFR.


Key Words: cytochrome P450 • eicosanoids • antilipidemic agents • hypertension • pressure-natriuresis • renal hemodynamics • arachidonic acid

Abbreviations: AII = angiotensin II • Dahl R rats = Dahl salt-resistant rats • Dahl S rats = Dahl salt-sensitive rats • FENa = fractional sodium excretion • GFR = glomerular filtration rate • 20-HETE = 20-hydroxyeicosatetraenoic acid • P4504A = cytochrome P450 4A enzymes • PMSF = phenylmethylsulfonyl fluoride • PPAR = peroxisome proliferator action receptor • PTH = parathyroid hormone • RPP = renal perfusion pressure • SDS = sodium dodecyl sulfate • TALH = thick ascending limb of the loop of Henle • TBS = Tris buffered saline • UNaV = sodium excretion




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
P. Luo, Y. Zhou, H.-H. Chang, J. Zhang, T. Seki, C.-Y. Wang, E. W. Inscho, and M.-H. Wang
Glomerular 20-HETE, EETs, and TGF-{beta}1 in diabetic nephropathy
Am J Physiol Renal Physiol, March 1, 2009; 296(3): F556 - F563.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. M. Williams, A. Sarkis, K. M. Hoagland, K. Fredrich, R. P. Ryan, C. Moreno, B. Lopez, J. Lazar, F. J. Fenoy, M. Sharma, et al.
Transfer of the CYP4A region of chromosome 5 from Lewis to Dahl S rats attenuates renal injury
Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1764 - F1777.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Minuz, H. Jiang, C. Fava, L. Turolo, S. Tacconelli, M. Ricci, P. Patrignani, A. Morganti, A. Lechi, and J. C. McGiff
Altered Release of Cytochrome P450 Metabolites of Arachidonic Acid in Renovascular Disease
Hypertension, May 1, 2008; 51(5): 1379 - 1385.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. M. Williams, A. Sarkis, B. Lopez, R. P. Ryan, A. K. Flasch, and R. J. Roman
Elevations in Renal Interstitial Hydrostatic Pressure and 20-Hydroxyeicosatetraenoic Acid Contribute to Pressure Natriuresis
Hypertension, March 1, 2007; 49(3): 687 - 694.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. J. Roman, K. M. Hoagland, B. Lopez, A. E. Kwitek, M. R. Garrett, J. P. Rapp, J. Lazar, H. J. Jacob, and A. Sarkis
Characterization of blood pressure and renal function in chromosome 5 congenic strains of Dahl S rats
Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1463 - F1471.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Zhou, H. Huang, H.-H. Chang, J. Du, J. F. Wu, C.-Y. Wang, and M.-H. Wang
Induction of Renal 20-Hydroxyeicosatetraenoic Acid by Clofibrate Attenuates High-Fat Diet-Induced Hypertension in Rats
J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 11 - 18.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. L. Schiffrin
More Evidence of Cardiorenal Protective Effects of Peroxisome Proliferator-Activated Receptor Activation
Hypertension, August 1, 2005; 46(2): 267 - 268.
[Full Text] [PDF]


Home page
HypertensionHome page
J. M. Williams, X. Zhao, M. H. Wang, J. D. Imig, and D. M. Pollock
Peroxisome Proliferator-Activated Receptor-{alpha} Activation Reduces Salt-Dependent Hypertension During Chronic Endothelin B Receptor Blockade
Hypertension, August 1, 2005; 46(2): 366 - 371.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Vera, M. Taylor, Q. Bohman, A. Flasch, R. J. Roman, and D. E. Stec
Fenofibrate Prevents the Development of Angiotensin II-Dependent Hypertension in Mice
Hypertension, April 1, 2005; 45(4): 730 - 735.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. M. Hoagland, A. K. Flasch, A. J. Dahly-Vernon, E. A. dos Santos, M. A. Knepper, and R. J. Roman
Elevated BSC-1 and ROMK Expression in Dahl Salt-Sensitive Rat Kidneys
Hypertension, April 1, 2004; 43(4): 860 - 865.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. M. Hoagland, K. G. Maier, and R. J. Roman
Contributions of 20-HETE to the Antihypertensive Effects of Tempol in Dahl Salt-Sensitive Rats
Hypertension, March 1, 2003; 41(3): 697 - 702.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. R. Ramsey, T. J. Berndt, and F. G. Knox
Indomethacin Blocks Enhanced Paracellular Backflux in Proximal Tubules
J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1449 - 1454.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. J. Roman
P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function
Physiol Rev, January 1, 2002; 82(1): 131 - 185.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. R. Jacobs and D. C. Zeldin
The lung HETEs (and EETs) up
Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H1 - H10.
[Abstract] [Full Text] [PDF]